PYAR, K. P. .; HLA, S. A.; KYAW, A. P. .; MAUNG, N. L. .; AUNG, Z. N. H. .; TUN, T. H. .; SHAN, M. A. .; AUNG, Y. L. .; LIN, K. Z. .; THU, S. P. .; KYAW, T. H.; YA, K. Z. .; KYAW, M. T.; ZAY PHYO AUNG; THAN TUN AUNG; AUNG THIT; AUNG HLAING WIN; MYO MIN THU; THUREIN WYNN; HAN LIN AUNG; LYNN HTET AUNG; LAY MAUNG MAUNG; YE MIN HEIN; MOE TUN ZAW; MYO MAUNG MAUNG; MYO MIN THANT. Efficacy, Safety of Baricitinib plus Remdesivir versus Standard Therapy (Remdesivir) in Patients with Severe COVID-19 Infection in Third Wave of Epidemics in Myanmar: Case Control Study. International Journal of Medical Science and Clinical Research Studies , [S. l.], v. 2, n. 3, p. 237–246, 2022. DOI: 10.47191/ijmscrs/v2-i3-07. Disponível em: https://ijmscr.org/index.php/ijmscrs/article/view/138. Acesso em: 21 nov. 2024.